What amount sold does Rio Grande Neurosciences, Inc. report in Form D filings?

The latest linked filings report $8.9M sold across 5 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Rio Grande Neurosciences, Inc.'s most recent SEC filing?

Rio Grande Neurosciences, Inc.'s most recent Form D filing was on 2016-02-10.

How many investors does Rio Grande Neurosciences, Inc. have?

The most recent Form D filing lists 9 investor(s).

What type of securities does Rio Grande Neurosciences, Inc. offer?

Rio Grande Neurosciences, Inc.'s SEC Form D filings indicate equity offerings.

Rio Grande Neurosciences, Inc.

CIK: 0001616132·Other Health Care·SANTA FE, NM·Corporation·Founded 2011

Reported Sold

$8,926,716

Total Filings

Identified Offerings

Last Filed

Feb 10, 2016

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Feb 10, 2016Form D — New notice

Reported sold: $828,412 · Target: $969,080

Rule 506(b)·9 investors

Jan 6, 2016Form D — New notice

Reported sold: $3,700,000 · Target: $3,700,000

Rule 506(b)·1 investor

Oct 26, 2015Form D — New notice

Reported sold: $2,000,000 · Target: $2,000,000

Rule 506(b)·11 investors

May 5, 2015Form D — New notice

Reported sold: $1,050,065 · Target: $8,000,000

Rule 506(b)·11 investors

Aug 19, 2014Form D — New notice

Reported sold: $1,348,239 · Target: $1,348,239

Rule 506(b)·34 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$400,000

Amendment Rate

Latest reported sold across 5 identified offerings

$8,926,716

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Stephen Juelsgaard

Related Person

Appears on 3 filings

Steven Gluckstern

Related Person

Appears on 3 filings

Blake Gurfein

Related Person

Appears on 2 filings

L. John Wilkerson

Related Person

Appears on 2 filings

Sean Hagberg

Related Person

Appears on 2 filings

Blake Gurfein

Related Person

Appears on 2 filings

Stephen Juelsgaard

Related Person

Appears on 2 filings

Steven M. Gluckstern

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 10, 2016	New	$969,080	$828,412	9
Jan 6, 2016	New	$3,700,000	$3,700,000	1
Oct 26, 2015	New	$2,000,000	$2,000,000	11
May 5, 2015	New	$8,000,000	$1,050,065	11
Aug 19, 2014	New	$1,348,239	$1,348,239	34

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

CCH Partners, Inc.

Other Health Care

Offering target: $1,000,000

Filed Oct 29, 2026